The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[3-Hydroxy-2,2-dimethyl-6-(4,4,4-trifluoro-butoxy)-chroman-4-yl]-N-methyl-methanesulfonamide ID: ALA340910
PubChem CID: 18329084
Max Phase: Preclinical
Molecular Formula: C17H24F3NO5S
Molecular Weight: 411.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN(C1c2cc(OCCCC(F)(F)F)ccc2OC(C)(C)C1O)S(C)(=O)=O
Standard InChI: InChI=1S/C17H24F3NO5S/c1-16(2)15(22)14(21(3)27(4,23)24)12-10-11(6-7-13(12)26-16)25-9-5-8-17(18,19)20/h6-7,10,14-15,22H,5,8-9H2,1-4H3
Standard InChI Key: SRZRLJWUQFIZRH-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
7.4417 -7.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1542 -5.8792 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.7292 -7.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4417 -6.2917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1542 -7.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1542 -8.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4417 -8.7792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7250 -8.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1542 -4.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1542 -5.0542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8667 -6.2917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0125 -7.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0125 -8.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5042 -4.2750 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.0167 -3.7917 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.3542 -4.9542 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.8750 -7.1292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8667 -5.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3000 -7.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3000 -8.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1500 -9.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8667 -7.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7292 -5.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8667 -5.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5875 -7.1292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5875 -6.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8667 -5.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 4 1 0
3 1 1 0
4 1 1 0
5 1 1 0
6 5 1 0
7 6 1 0
8 3 1 0
9 24 1 0
10 2 2 0
11 2 2 0
12 3 2 0
13 8 2 0
14 9 1 0
15 9 1 0
16 9 1 0
17 5 1 0
18 2 1 0
19 12 1 0
20 19 2 0
21 6 1 0
22 6 1 0
23 4 1 0
24 27 1 0
25 19 1 0
26 25 1 0
27 26 1 0
7 8 1 0
20 13 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 411.44Molecular Weight (Monoisotopic): 411.1327AlogP: 2.87#Rotatable Bonds: 6Polar Surface Area: 76.07Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.23CX Basic pKa: ┄CX LogP: 1.79CX LogD: 1.79Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.73Np Likeness Score: -0.15
References 1. Gerlach U, Brendel J, Lang HJ, Paulus EF, Weidmann K, Brüggemann A, Busch AE, Suessbrich H, Bleich M, Greger R.. (2001) Synthesis and activity of novel and selective I(Ks)-channel blockers., 44 (23): [PMID:11689069 ] [10.1021/jm0109255 ]